UnknownNot Applicable

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation

Egypt16 participantsStarted 2017-08-15

Plain-language summary

Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with missing maxillary anterior toot teeth.
✓. Thin gingival biotype.
✓. Adequate inter-arch space for placement of the implant prosthetic part.
✓. Good oral hygiene where gingival index is (0, 1) (Loe and Silness 1963).

Exclusion criteria

✕. Patient with medical condition that is contraindicated with the surgical procedure
✕. Patients receiving treatment that affect the healing ability.
✕. Patients with local pathological defects related to the area of interest.
✕. Smokers or pregnant women.
✕. Patients with parafunctional habits that may jeopardize the implant longevity and affect the results of the study.

What they're measuring

Crestal bone resorption

Timeframe: 6 months

Trial details

NCT IDNCT03219944

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-01-01

Contact for this trial

may mo kamal

01063392983 maykamalmo@gmail.com

View on ClinicalTrials.gov More Patients With at Least Single Missing Anterior Tooth trials